References
- Fritsch P, Schwinger W, Schwantzer G, Lackner H, Sovinz P, Wendelin G,
Benesch M, Sipurzynski S, Urban C. Peripheral blood stem cell
mobilization with pegfilgrastim compared to filgrastim in children and
young adults with malignancies. Pediatr Blood Cancer 2010;54:134-7.
- Cesaro
S, Tintori V, Nesi
F, Schiavello
E, Calore E,
Dallorso
S, Migliavacca M,
Capolsini
I, Desantis R,
Caselli
D, Fagioli
F, Luksch R, Panizzolo I, Tridello G,
Prete
A. A prospective study on the efficacy of mobilization of autologous
peripheral stem cells in pediatric oncohematology patients.
Transfusion 2013 Jul;53(7):1501-9.
- Duong HK, Savani BN, Copelan E, Devine S, Costa LJ, Wingard JR,
Shaughnessy P, Majhail N, Perales MA, Cutler CS, Bensinger W, Litzow
MR, Mohty M, Champlin RE, Leather H, Giralt S, Carpenter PA.
Peripheral blood progenitor cell mobilization for autologous and
allogeneic hematopoietic cell transplantation: guidelines from the
American Society for Blood and Marrow Transplantation. Biol Blood
Marrow Transplant. 2014 Sep;20(9):1262-73.
- Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D,
Madrigal A, Fraundorfer K. The EBMT activity survey 2009: trends over
the past five years. Bone MarrowTransplant 2011;46:485-501.
- Pierelli L, Perseghin P, Marchetti M, Accorso P, Fanin R, Messina C,
Olivieri A, Risso M, Salvaneschi L. Bosi A for Società Italiana di
Emaferesi and manipolazione Cellulare (SIDEM) and Gruppo Italiano
Trapianto di midollo Osseo (GITMO). Best practice for peripheral blood
progenitor cell mobilization and collection in adults and children:
results of a Società Italiana Di Emaferesi e Manipolazione Cellulare
(SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus
process. Transfusion 2012;52: 893-905.
- Cesaro S, Zanazzo AG, Frenos S, Luksch R, Pegoraro A, Tridello G,
Dallorso S. A Phase II study on the safety and efficacy of a single
dose of pegfilgrastim for mobilization and transplantation of
autologous hematopoietic stem cells in pediatric oncohematology
patients. Transfusion 2011;51:2480-7.
- Arvedson T, O’Kelly J, Yang BB. Design Rationale and Development
Approach for Pegfilgrastim as a Long-Acting Granulocyte
Colony-Stimulating Factor. BioDrugs. 2015 Jun;29(3):185-98. doi:
10.1007/s40259-015-0127-4.
- Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy: An
overview. Asian journal of pharmaceutical s c i e n c e s ( 2 0 1 6 )
337–348
- Kuan
JW, Su
AT, Leong
CF. Pegylated granulocyte-colony stimulating factor versus
non-pegylated granulocyte-colony stimulating factor for peripheral
blood stem cell mobilization: A systematic review and meta-analysis. J
Clin Apher 2017 Dec;32(6):517-542.
- Wendelin G, Lackner H, Schwinger W, et al. Once-per-cycle
Pegfilgrastim versus daily Filgrastim in pediatric patients with Ewing
sarcoma. J Pediatr Hematol Oncol 2005;27:449–451.
- te Poele EM, Kamps WA, Tamminga RY, et al. Pegfilgrastim in pedaitric
cancer patients. J Paediatr Hematol Oncol 2005;27:627–629.
- Andre N, Kababri ME, Bertrand P, et al. Safety and efficacy of
PegFilgrastim in children with cancer receiving myelosuppressive
chemotherapy. J Clin Oncol 2000;18:2522–2528.
- Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA,
Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM.
Randomized trial and pharmacokinetic study of pegfilgrastim versus
filgrastim after dose-intensive chemotherapy in young adults and
children with sarcomas. Clin Cancer Res. 2009 Dec 1;15(23):7361-7.
- Cesaro S, Nesi F, Tridello G, Abate M, Panizzolo IS, Balter R, Calore
E. A randomized, non-inferiority study comparing efficacy and safety
of a single dose of pegfilgrastim versus daily filgrastim in pediatric
patients after autologous peripheral blood stem cell transplant. PLoS
One. 2013;8(1):e53252.
- Dallorso S, Berger M, Caviglia I, Emanueli T, Faraci M, Scarso L,
Fagioli F, Haupt R. Prospective single-arm study of pegfilgrastim
activity and safety in children with poor risk malignant tumours
receiving chemotherapy. Bone Marrow Transplant 2008;42:507-13.
- Merlin E, Zohar S, Jérôme C, Veyrat-Masson R, Marceau G, Paillard C,
Auvrignon A, Le Moine P, Gandemer V, Sapin V, Halle P, Boiret-Dupré N,
Chevret S, Deméocq F, Dubray C, Kanold J. Hematopoietic progenitor
cell mobilization and harvesting in children with malignancies: do the
advantages of pegfilgrastim really translate into clinical benefit?
Bone Marrow Transplant 2009;43:919-25.
- Carter T, Jensen J, Baker D, Cole G. Use of Pegylated Granulocyte
Colony Stimulating Factor Mobilisation for Autologous Peripheral Blood
Stem Cell Rescue- A Paediatric Experience J Pediatr Hematol Oncol _
Volume 27, Number 9, September 2005.